Keynote Speakers

Contemporary Management of Intrahepatic Cholangiocarcinoma
22 September 2020 (Tuesday) | 13:15-13:45hrs

Dr. Pawlik received his undergraduate degree from Georgetown University and his medical degree from Tufts University School of Medicine. Dr. Pawlik completed surgical training at the University of Michigan Hospital and spent two years at the Massachusetts General Hospital as a surgical oncology research fellow. He then went on for advanced training in surgical oncology at The University of Texas M. D. Anderson Cancer Center in Houston. Dr. Pawlik’s main clinical interests include alimentary tract surgery, with a special interest in hepatic, pancreatic and biliary diseases. Dr. Pawlik also has an interest in medical ethics and completed a fellowship in medical ethics at the Harvard School of Public Health as well as a Masters in Theology from Harvard Divinity School in Boston. In addition, Dr. Pawlik was the recipient of a Clinical and Translational Science Award (CTSA) KL2 Research Scholar Award and received a PhD from the Johns Hopkins Bloomberg School of Public Health in Clinical Investigations.

Dr. Pawlik took his first faculty appointment at Johns Hopkins in 2005, where he was Professor of Surgery and Oncology, as well as the John L. Cameron Chair of Alimentary Tract Diseases and the Chief of the Division of Surgical Oncology until 2016. Dr. Pawlik currently is the Chair of Surgery at The Ohio State University Wexner Medical Center where he holds The Urban Meyer III and Shelley Meyer Chair for Cancer Research. Dr. Pawlik also serves as the Treasurer / Secretary of The Ohio State University Practice Plan. Dr. Pawlik has given over 450 invited talks both nationally and internationally in 30 different countries. Dr. Pawlik has published over 1,000 articles and 90 book chapters, in addition to editing eight surgical textbooks. His research has been cited over 35,000 times with an H-index of 98. Dr. Pawlik serves on multiple editorial boards and is Editor-in-Chief of Journal of Gastrointestinal Surgery, Deputy Editor of JAMA Surgery, as well as an Associate Editor for Annals of Surgical Oncology. Dr. Pawlik has served on the executive council of several of the premier surgical associations in the United States. Dr. Pawlik is a member of multiple surgical societies including the Society of Surgical Oncology, Society of Surgery of the Alimentary Tract, American Surgical Association, Halsted Society, and Society of Clinical Surgery. Dr. Pawlik is a past-President of the Association for Academic Surgery, as well as the current President-elect of the Americas Hepato-Pancreato-Biliary Association. Dr. Pawlik’s international contributions have been recognized through his honorary memberships in the Royal Australasian College of Surgeons, Brazilian Society of Surgical Oncology, Mexican Association for Surgery of the Alimentary Tract, as well as the Society of General Surgeons of Perú. Dr. Pawlik’s research focuses on determinations of factors associated with prognosis and staging of gastrointestinal cancers, as well as the economics of cancer care. He also studies patient/physician communication and patient engagement, as well as patient perception of cancer-care goals. Dr. Pawlik has consistently been recognized by Castle Connolly as one of America’s “Top Docs.”

Is it Possible to Cure Pancreas Cancer in the Era of Precision Medicine?
22 September 2020 (Tuesday) | 13:15-13:45hrs

Dr Sang-Jae Park is the Director, Research Institute of National Cancer Center, Korea & Staff Surgeon, Cancer for Liver Cancer/ Liver and Pancreatobiliary Pancreatic Cancer Branch, National Cancer Center, Korea

Education

1. 1984-1990 | M.D. Seoul National University College of Medicine, Seoul, Korea
2. 1994-1999 | M.S. Seoul National University College of Medicine, Seoul, Korea
3. 2000-2004 | ph.D. Seoul National University College of Medicine, Seoul, Korea

Training

1. 1991-1995 | Residency in General Surgery, Seoul National University Hospital, Seoul, Korea
2. 1998-2000 | Fellowship in General Surgery, Seoul National University Hospital, Seoul, Korea
3. 2006-2007 | Research fellow at the Transplantation Division in UCSF, USA

Faculty Appointment

1. 2000-present | Center for Liver Cancer, National Cancer Center, Korea | Liver and Pancreatobiliary Cancer Branch, National Cancer Center, Korea
2. 2010-2014 | Head, Center for Liver Cancer, National Cancer Center, Korea
3. 2014-2017 | Head, Dep. of Surgery, National Cancer Center Hospital, Korea
4. 2018-present | Director, Research Institute of National Cancer Center, Korea

Academic Activities

• 2017-present | Director, Scientific Committee of Korean Association of HBP Surgery
• 2008-2009 | Secretary, Korean Liver Cancer Association
• 1995-present | Member, Korean Surgical Society
• 2001-present | Member, Korean Association of HBP Surgery
• 2002-present | Member, Korean Liver Cancer Association
• 2005-present | Member, International Society of HBP Surgery
• 2006-present | Member, International Society of Pancreatology

Publications

• International 94, Korean 13

Current Management of Biliary Complications Following Major HPB Surgery
22 September 2020 (Tuesday) | 13:15-13:45hrs

Professor Rowan W. Parks qualified from Queens University Belfast in 1989. He pursued his surgical training in Northern Ireland and then undertook a clinical fellowship in HPB surgery at the Royal Infirmary of Edinburgh. He was appointed a Senior Lecturer in Surgery and Honorary Consultant Surgeon in the Royal Infirmary of Edinburgh in 1999, was subsequently promoted to Reader in Surgery in 2006 and was awarded a person chair as Professor of Surgical Sciences at the University of Edinburgh in 2010.

Professor Parks has a specialist interest in HPB surgery. He has published more than 160 papers, written 39 book chapters and has authored / edited 7 surgical textbooks. He has been awarded several prestigious prizes and travelling fellowships and has given a number of eponymous lectures.

Professor Parks is currently Vice President of the Royal College of Surgeons of Edinburgh (RCSEd); Deputy Director of Medicine, NHS Education for Scotland (NES) and Treasurer of the European-African Hepato-Pancreatico-Biliary Association (E-AHPBA). He is also immediate Past-President of the Association of Surgeons of Great Britain and Ireland (ASGBI); Immediate Past-President of the Great Britain & Ireland Hepato-Pancreato-Biliary Association (GBIHPBA);

Immediate Past-Chairman of the Scientific Programme Committee of the International Hepato-Pancreato–Biliary Association (IHPBA) and Past-Director of the James IV Association.

Laparoscopic Surgery for Pancreatic Head Malignancies: Evidence Based Perspective
23 September 2020 (Wednesday) | 13:15-13:45hrs

Horacio Asbun, M.D., FACS, is  Chief of Hepatobiliary and Pancreatic Surgery at Miami Cancer Institute and Professor of Surgery at Mayo Clinic College of Medicine and Science. Prior to this role, he served as Chairman of General Surgery at Mayo Clinic in Jacksonville, Fla.. (2008-2018)

Dr. Asbun is President-Elect and will be President (2020-2021) of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) and Executive Member of the Board of Governors. He also has served as a member of the Executive Council of the American Hepato-Pancreatic Biliary Association (AHPBA), Chairman of the Video-Based Education of the American College of Surgeons and is a founding Board Member of The G4 Alliance, the International Laparoscopic Liver Society and the International Minimally Invasive Pancreas Surgery consortium

Dr Asbun is the Editor-in-Chief of the American College of Surgeons Multimedia Atlas of Surgery and is on the Editorial Board of Surgical Endoscopy. He has served as a panel member on the National Comprehensive Cancer Network (NCCN) guidelines for pancreatic cancer and a member of 25 Medical Societies He has been, and currently is a member, Chair or Co-Chair of multiple Committees on several major US surgical societies

Dr Asbun is a member of multiple international expert’s surgical initiatives and expert study groups. Among them, International Study Group of Pancreas Surgery (ISGPS), Tokyo Guidelines (TG 18), European Guidelines on Laparoscopic Liver Surgery (EGMLLS), International Consensus on Laparoscopic Liver Resection (ICLLR), International Consensus on Prevention of Bile Duct Injury. He has served as the Chair of the Evidence-Based, International Guidelines in Minimally Invasive Pancreas Resection (IG-MIPR). He is also a founding member of the International Minimally Invasive Pancreas Surgery Consortium (IMIPS).

Dr Asbun has published more than 150 peered-reviewed scientific articles and 110 peer-reviewed surgical videos. He is author of over 35 book chapters and editor of 6 Surgical Books. He serves as a reviewer for numerous scientific journals. He directs and teaches national and international courses on surgery and speaks frequently at scientific conferences around the world, with, to-date, more than 240 presentations in the US and over 450 invited presentations in Europe, Asia, Africa, Oceania, Central and South America. He is an Honorary Fellow of several International Surgical Societies and has received multiple awards.

His publications are in the areas of liver, pancreas, biliary and endocrine surgery, minimal invasive surgery, surgical oncology, as well as basic science research in the field of surgical oncology.

Education and Training in Liver Transplantation: Past, Present and Future
23 September 2020 (Wednesday) | 13:15-13:45hrs

William Chapman, M.D., F.A.C.S., is a Professor of Surgery, the Chief of Abdominal Organ Transplant and the Eugene M. Bricker Chair of Surgery at Washington University in St. Louis, as well as the Chief of the Division of General Surgery at Barnes Jewish Hospital. He has been an active member in many surgical societies, including President of the AHPBA for the 2013-2014 year and President of the Western Surgery Association for the 2015-2016 year and, most recently, Treasurer of the ASTS for the 2018-2019 year. He is currently a director of the American Board of Surgery and is on the editorial board of six surgical journals, including the American Journal of Transplantation, Transplantation, Journal of the American College of Surgeons, Annals of Surgery, and Journal of Gastrointestinal Surgery. His clinical interest is adult and pediatric liver transplantation, adult kidney transplantation, and HPB surgery for both benign and malignant diseases.

What are the Essential Requirements for an HPB Service to Deliver Quality Outcomes?
23 September 2020 (Wednesday) | 13:15-13:45hrs

Pierre-Alain Clavien, MD, PhD, FACS (hon), ASA (hon), FRCS (Eng), FRCS (Ed), is a worldwide renowned surgeon-scientist, currently professor and chairman of the Department of Surgery in Zurich, Division of Surgery & Transplantation, University Hospital Zurich, Switzerland. His main interests are the various aspects of transplantation and liver surgery. Since 1994, he has been running an active basic science laboratory, areas of research include organ preservation, liver ischemia-reperfusion injury and liver regeneration, pathogenesis of cancer as well as outcome research with publication in Science, Nature, PNAS, Annals of Surgery, Gastroenterology, Lancet and NEJM. Dr. Clavien has also developed a simple and widely used system to evaluate complications after surgery, which holds his name.

He was appointed Associate Editor of Journal of Hepatology and of Annals of Surgery to cover the liver topics, and Editor for the ESA articles in Annals of Surgery.